Dominant-activating mutations in the RET (rearranged during transfection) proto-oncogene, a receptor tyrosine kinase, are causally associated with the development of multiple endocrine neoplasia type 2A (MEN2A) syndrome. Such oncogenic RET mutations induce its ligand-independent constitutive activation, but whether it spreads identical signaling to ligand-induced signaling is uncertain. To address this question, we designed a cellular model in which RET can be activated either by its natural ligand, or alternatively, by controlled dimerization of the protein that mimics MEN2A dimerization. We have shown that controlled dimerization leaves proximal RET signaling intact but impacts substantially on the tuning of the distal AKT kinase activation (delayed and sustained). In marked contrast, distal activation of ERK remained unaffected. We further demonstrated that specific temporal adjustment of ligand-induced AKT activation is dependent upon a lipid-based cholesterol-sensitive environment, and this control step is bypassed by MEN2A RET mutants. Therefore, these studies revealed that MEN2A mutations propagate previously unappreciated subtle differences in signaling pathways and unravel a role for lipid rafts in the temporal regulation of AKT activation.
To address this issue, we have generated a chimeric RET-Fv protein that can be alternatively activated in the same cell, either with the natural ligand GDNF or with a synthetic bivalent dimerizing ligand (19) . The latter mimicked ligand-independent RET dimerization by MEN2A mutants. This induced activation of RET specifically resulted in altered AKT activation but not ERK activation. Furthermore, we demonstrated that a lipid-based cholesterol-sensitive environment regulates the tuning of GDNF-induced AKT activation, suggesting a role of lipid rafts. Finally, we showed that MEN2A mutants escape from this control step. Therefore, these studies revealed complex alterations in oncogenic signaling by MEN2A RET mutants.
EXPERIMENTAL PROCEDURES
Antibodies, Reagents, and DNA Constructs-Phospho-tyrosine (4G10), hemagglutinin (HA), flotillin, and human transferrin receptor antibodies were from Upstate Biotechnology (Lake Placid, NY), Covance Research (Berkeley, CA), BD Transduction Laboratories, and Zymed Laboratories (South San Francisco, CA), respectively. Proteinspecific anti-phospho antibodies were from Cell Signaling Technology (Beverly, MA). Anti-RET was described elsewhere (20) . Anti-phosphoRETs (Tyr-1015 or Tyr-1062) were generously provided by Dr. Massimo Santoro (21) . Lipofectamine 2000, human GDNF, protease inhibitors, monensin, and brefeldin A were from Invitrogen, Promega Corp. (Madison, WI), Roche Diagnostics, BD Biosciences, and Calbiochem, respectively. MTT, Triton X-100, methyl-␤-cyclodextrin (MBC), and anisomycin were from Sigma. AP20187 (AP) was provided by Ariad Pharmaceuticals (Cambridge, MA). The HA-tagged AP-binding domain (Fv) was subcloned from the Ariad pC 4 -F v 1E vector, into the ApaI/XbaI sites of the pcDNA3.1(ϩ) vector (Invitrogen). The Ret9 cDNA (20) was mutated by PCR to suppress the stop codon and subcloned into the HindIII/XbaI sites of the pcDNA-Fv vector. The HA-GFR␣1 cDNA kindly provided by Dr. Carlos Ibanez (22) was subcloned into the BamHI/EcoRI sites of the pBabe retroviral vector (23) .
Cell Culture and Transfections-Rat-1 cells, immortalized rat fibroblasts expressing neither Ret nor GFR␣1, were maintained in complete medium: Dulbecco's modified Eagle's medium with 10% fetal bovine serum and antibiotics (all from Sigma). Cells were transfected with RetFv-and GFR␣1-containing vectors with the use of Lipofectamine according to manufacturer's recommendations. Stably transfected cells were selected in complete medium with G418 (1 mg/ml) and/or puromycin (2 g/ml) (both from Sigma). Rat-1 cell clones transformed by RET MEN2A mutants (24) were maintained in complete medium with puromycin (2 g/ml). MEN2A cells were further transfected with GFR␣1, and stable clones (termed M␣) were selected with G418 (1 mg/ml) and puromycin (2 g/ml).
Stimulations and Immunoblotting-Equal numbers of cells were seeded in plates to achieve ϳ60% confluence in 24 h and serum-starved for 4 h prior to stimulation. Cells were stimulated for the indicated period of time with either 10 ng/ml GDNF or 100 nM AP20187 in serum-free medium and lysed at 4°C for 20 min in radioimmune precipitation buffer (150 mM NaCl, 50 mM Tris-HCl (pH 7.2), 1% Triton X-100, 1% Sodium deoxycholate, 0.05% SDS, 4 mM NaVO 4 , 5 mM EGTA, and protease inhibitors). Precleared lysates (10 min at 13,000 rpm) were subjected to SDS-PAGE and Western blotting using the relevant antibody as described previously (25) . Densitometry of the blots was assessed using a Fluor-S multi-imager system (Bio-Rad).
DRM Assay-Cells were scrapped, rinsed once with phosphate-buffered saline, and lysed at 3 mg of protein/ml in a final volume of 0.5 ml of ice-cold TNE buffer (150 mM NaCl, 25 mM Tris-HCl (pH 7.2), 4 mM NaVO 4 , 5 mM EGTA, and protease inhibitors) containing 0.5% Triton X-100. Lysates were homogenized five times through a 23-gauge needle and incubated with constant agitation for 30 min at 4°C. They were then mixed with 1 ml of 60% saccharose in TNE buffer containing 0.1% Triton X-100 and transferred to ultracentrifuge tubes. The samples were overlaid by a saccharose gradient (2 ml of 30% saccharose followed by 1 ml of 25, 20, 17.5, 15, 12.5 , and 5% saccharose in TNE buffer containing 0.1% Triton X-100) and centrifuged for 16 h at 39,000 rpm in a Beckman SW41 rotor at 4°C. The gradient was fractionated into 1-ml fractions (see Fig. 6B, 1 .15-ml fractions) from the top of the tube, except for the last one that contained 1.5 ml. Aliquots of each fraction were analyzed by SDS-PAGE and immunoblotting.
Cellular Cholesterol Depletion and Brefeldin A/Monensin TreatmentCells prepared as described above were incubated in serum-free medium containing MBC (10 mM) and 50 mM Hepes for 20 min at 37°C with constant agitation. Cells were then rinsed twice in phosphatebuffered saline, stimulated, and lysed to isolate DRMs. To abrogate RET protein maturation, cells were treated or not with 2.5 g/ml brefeldin A and 0.66 l/ml monensin (Golgi stop) in serum-free Dulbecco's modified Eagle's medium for 6 h and further stimulated with AP for the indicated period of time, before being processed for immunoblotting analysis.
Cell Growth and TUNEL Assays-Cells were plated at 500 cells/well in 96-well plates in complete medium with GDNF (10 ng/ml) or AP (100 nM), the growth medium being changed every 3 days. Every 2 days, cells were harvested, and an MTT test was realized for each condition of stimulation; 30 l of MTT (7.5 mg/ml in phosphate-buffered saline) was added to each well, and cells were incubated for 4 h at 37°C. The medium was then replaced with 100 l of Me 2 SO with 0.04 N HCl. OD was read at 492 nm. The measured absorbance is proportional to the number of live cells present. For TUNEL assay, M␣ cells were plated on coverslips at 7 ϫ 10 4 cells/well in Dulbecco's modified Eagle's medium containing 1% fetal bovine serum, overnight, and stimulated with 50 ng/ml GDNF for 1 h in the same medium before being incubated with anisomycin (1 g/ml) for 5 h. A TUNEL assay was performed according to the supplier's instructions (in situ cell death detection kit, Roche Diagnostics).
RESULTS

Controlled Homodimerization and Activation of RET-
The inducible GDNF/GFR␣1-independent activation system of RET is controlled by the synthetic bivalent dimerizing ligand AP. It is based on the ability of a fusion protein (RET-Fv), containing RET linked to an AP-binding domain (Fv), to be induced to homodimerize in the presence of AP, leading to RET activation (Fig. 1A) . Both RET-Fv and GFR␣1 were stably expressed in Rat-1 fibroblastic cells so that RET-Fv can be activated alternatively with GDNF or AP treatment. Fig. 1A shows the expression of RET-Fv and GFR␣1 in representative Rat-1 fibroblast clones. The two RET species correspond to the incompletely glycosylated protein present in the endoplasmic reticulum (162 kDa, major form in Rat-1 cells) and to the fully glycosylated protein expressed at the plasma membrane (182 kDa) (26) . Similarly, the 65-kDa form of GFR␣1 was expressed on the cellular surface, whereas the 55-kDa form was not (not shown) and was assumed to correspond to an immature GFR␣1 product.
Stimulation of RET-Fv/GFR␣1-expressing cells with an optimal concentration of AP or GDNF for 15 min induced a comparable activation of mature 182-kDa RET proteins, as detected with an antibody specific to phosphorylated autocatalytic residue Y905RET (Fig. 1B, upper  panel) . However, in contrast to GDNF, AP diffused into the cytoplasm and then bound to and activated the immature 162-kDa Ret protein. This is similar to what is typically observed with MEN2A RET mutants in which both the mature and the immature forms of RET are activated. Despite the additional activation of the immature form of RET, a comparable increase in tyrosine phosphorylation of cellular proteins was detected after either GDNF or AP stimulation (Fig. 1B, lower panel) . It would appear that the addition of the Fv module to the cytoplasmic tail of RET does not obviously alter RET activation and signaling since a similar pattern of tyrosine phosphorylation was observed when cells were transfected with wild type RET instead of RET-Fv and stimulated with GDNF (Fig. 1B) . Taken together, these results indicated that homodimerization of RET can lead to its efficient activation without the requirement for GDNF/GFR␣1 complex. They also suggested that activation of the intracellular immature 162-kDa Ret protein does not contribute much to the RET-dependent pattern of tyrosine phosphorylation.
GDNF/GFR␣1-independent RET Activation Leads to an Altered Cellular Outcome-Next, we investigated whether activation of RET by AP or GDNF can differently affect biological outcomes. RET-Fv/GFR␣1-expressing cells were chronically stimulated with either GDNF or AP, and the growth rate was monitored. Neither AP nor GDNF stimulated growth rate during the first 6 days of culture (Fig. 2) . After 8 days of culture, both non-stimulated and GDNF-stimulated cells grew in an even monolayer and displayed normal contact inhibition, as shown on representative May-Grunwald-Giemsa staining of cells after 10 days of culture. As a consequence, these cells stopped growing. In contrast, AP-stimulated cells began to overgrow one another, indicating that they had lost the ability to be contact inhibited. These results indicated the existence of specific AP-mediated cellular outcome(s), suggesting that GDNF/GFR␣1-independent RET activation leads to alterations of intracellular signaling pathways.
GDNF/GFR␣1-independent RET Activation Impacts on AKT Regulation-We next tested whether activation of RET by AP or GDNF can translate into different, or differently regulated, RET-mediated signaling pathways. We first monitored the extent of RET autophosphorylation using two other antibodies specific to phosphorylated Y1015RET and Y1062RET. Fig. 3A shows that phosphorylation over a time course of these autocatalytic residues was comparably achieved by GDNF or AP stimulation. Together with the comparable phosphorylation of Y905RET depicted in Fig. 1 , these results indicate that AP or GDNF stimulation leads to similar activation of RET tyrosine kinase. It is of note that RET phosphorylation in Rat-1 cells remained high after 2 h of stimulation and that it could last for 6 h before declining (see Fig.  6A ). Similar results were obtained with wild type RET instead of RET-Fv (not shown), indicating that the Fv-binding module is not involved in the long lasting phosphorylation of RET in Rat-1 cells. Y1015RET and Y1062RET are binding sites for PLC␥ and Shc/Dok4 -5/IRS-1/FRS-2, respectively. The bound molecular partners are in turn phosphorylated by RET (3). Fig. 3A shows that both Shc and PLC␥ were phosphorylated in a comparable manner following GDNF or AP stimulation and that their kinetics of phosphorylation paralleled those of RET. These results implied that RET activation by AP or GDNF does not influence proximal RET signaling, i.e. autophosphorylation of RET and the resulting phosphorylation of the molecular partners Shc and PLC␥.
We next examined the activation of downstream pathways by looking at ERK and AKT phosphorylation. GDNF induced a transient phosphorylation of ERK and AKT (Fig. 3) . Therefore, both Ras/ERK and PI3K/ AKT signaling pathways can be attenuated even with the prolonged phosphorylation of RET observed in Rat-1 cells. As compared with GDNF, AP stimulated ERK phosphorylation to a similar amplitude and duration. However, in marked contrast, the kinetics of AP-stimulated AKT phosphorylation was delayed and sustained for several hours (Fig.  3, A and B) . Kinetic alteration of AKT phosphorylation was detected on both serine 473 and threonine 308, which additively activate AKT (28) . It should be emphasized that AP does not directly affect AKT activation since no alteration of AKT phosphorylation could be detected following GDNF treatment of cells expressing RET (instead of RET-Fv) in the presence of AP (not shown). These results indicated that GDNF/ GFR␣1-independent RET activation translates into differently regulated AKT activation, without really affecting ERK activation.
Neither Signaling from GFR␣1 Alone nor from Immature Forms of RET Contributes to AKT Phosphorylation-Since GDNF has been reported to signal independently of RET via GFR␣1 (29, 30) , it was important to evaluate whether signaling originating from GFR␣1 alone could contribute to AKT and ERK phosphorylation in Rat-1 cells. We thus made use of Rat-1 clones expressing GFR␣1 only and have been unable to detect any phosphorylation of AKT and ERK following GDNF stimulation of these clones (Fig. 4A) . Next, we evaluated whether APactivated immature 162-kDa forms of RET-Fv were involved in the differential phosphorylation of AKT. To address this issue, cells were treated with brefeldin A and monensin to abrogate RET maturation and delivery to the plasma membrane (31) . The combined use of the two protein maturation blocking drugs was favored because under our experimental conditions, each drug alone was not efficient enough to fully prevent apparition of mature RET proteins (not shown). Cellular treatment for 6 h with the two drugs efficiently blocked the expression of the plasma membrane-localized mature forms of RET while increasing the expression of the endoplasmic reticulum-associated immature 162-kDa form of RET (Fig. 4B) . Under these conditions, AP stimulation of cells could still induce phosphorylation of the immature form. Interestingly, phosphorylation of Shc was also detectable, indicating that activated endoplasmic reticulum-associated immature 162-kDa forms of RET can recruit molecular partners. However, these activated forms of RET made no detectable contribution to AKT and ERK activation. These data, together with the observation that additional activation of immature forms of RET did not modify the tyrosine phosphorylation pattern (Fig. 1B) , strongly suggest that immature forms of RET do not contribute to the signaling pathways monitored here.
GDNF/GFR␣1-independent RET Activation Does Not Associate with DRMs-GDNF/GFR␣1-stimulated RET associates with the raft-related DRMs, and this association has been correlated with the control of downstream signaling (4, 5) . Thus, to gain an insight into the mechanism(s) responsible for the differential regulation of AKT activation, we asked whether AP stimulation could also induce the association of RET with DRMs. As expected, GDNF stimulation induced an association of mature forms of RET-Fv with DRMs (Fig. 5A ). Flotillin and transferrin receptor were used as positive and negative markers, respectively, of DRM-associated proteins. Although RET must associate with GFR␣1 to be activated by GDNF, more than 60% of phosphorylated RET-Fv was recovered in soluble fractions (Fig. 5B) . This does not seem to reflect a large movement of RET out of DRMs after recruitment and activation since RET remained associated with DRMs for several hours after the beginning of the stimulation in Rat-1 cells (Fig. 5B , and see also Fig. 6A ). These results suggested that RET association with DRMs is weaker than GFR␣1 association and that it can be partly disrupted by non-ionic detergents. In marked contrast to these results, RET association with DRMs was not evident upon AP stimulation. Similarly, RET proteins carrying a representative MEN2A mutation at Cys-634 (24) were not recovered in the DRM fractions (Fig. 5A) . These results clearly demonstrated a difference in the association (or the strength of association) of RET with DRMs between GDNF-dependent and GDNF/GFR␣1-independent RET activation.
RET Association with DRMs Correlates with Specific Regulation of AKT-
The above results raised the possibility that tight regulation of AKT, but not ERK, phosphorylation is linked to DRM association of RET. This hypothesis was tested in two different ways. First, association of proteins with DRMs has been shown to be sensitive to the cholesterol-depleting drug MBC (32) . Preincubation of Rat-1 cells for 20 min with 10 mM MBC before stimulation did not affect RET phosphorylation and its total protein level (not shown). However, it significantly delayed the detectable GDNF-induced association of phosphorylated RET with DRMs (Fig. 6A) . Quantification by densitometry indicates a 2-h delay in the maximal association of phosphorylated RET with DRMs (see -fold increase). Remarkably, GDNF-stimulated AKT phosphorylation was also delayed, reaching a maximum 2 h after the beginning of the stimulation and declining thereafter. Under these conditions, AP-mediated AKT phosphorylation was barely affected by MBC treatment of the cells, ruling out a massive effect of the drug on cellular membranes (33) and supporting a non-association of RET with DRMs when activated by AP. Interestingly, the AKT phosphorylation level rapidly declined after 2 h of GDNF stimulation in the presence of MBC, whereas it remained high after AP stimulation (Fig. 6A) . This indicated that RET association with DRMs correlates not only with a rapid AKT phosphorylation but also with a subsequent efficient AKT dephosphorylation. Altogether, these data underscored a strong correlation between DRM association of RET and a specific regulation of AKT phosphorylation after GDNF stimulation.
Second, we took advantage of the MEN2A mutants that do not associate with DRMs (Fig. 5A) . MEN2A mutation at Cys-634 has been shown to activate AKT in Rat-1 fibroblastic cells (24) . Because MEN2A mutants can bind to GDNF in the presence of GFR␣1 (35), we reasoned that GDNF/GFR␣1 stimulation of RET mutants may lead to its associ- ation with DRMs and impact on AKT phosphorylation. Thus, cells expressing MEN2A RET mutants were transfected with GFR␣1, and stable clones were generated (termed M␣). As expected, in the absence of GFR␣1, GDNF treatment of cells expressing MEN2A RET mutants did not induce an association of RET with DRMs (not shown). In contrast, Fig. 6B shows that GDNF stimulation of M␣ induces association of MEN2A RET mutants with DRMs without affecting their constitutive phosphorylation. As seen with RET-Fv in Fig. 5A , only the mature form of the MEN2A RET mutant (170 kDa, plasma membrane-located) associates with DRMs. Importantly, this association parallels a decrease of AKT phosphorylation (Fig. 6C) , therefore strengthening a role for DRMs in the regulation of AKT activation. The extent of AKT dephosphorylation ranged between 40 and 80% in three independent M␣ clones and lasted up to 6 h after GDNF cellular treatment (not shown). Because AKT can provide a survival advantage in several cell types (28), we evaluated the biological relevance of the observed decrease in AKT activation by treating the M␣ cells with the apoptosis-inducing drug anisomycin (35) . Fig. 6D shows that GDNF-treated cells were slightly more sensitive to apoptosis (5.6%) than non-stimulated cells, as revealed by a TUNEL assay. However, following anisomycin treatment, GDNF stimulation induced a 30% increase in apoptotic cells. Thus, the observed decreased in AKT activation is of biological significance.
Altogether, these two approaches strongly supported a role for DRMs in the specific regulation of AKT phosphorylation. In addition, they suggested that the intracellular signaling triggered by MEN2A RET mutants escape from a lipid raft-related control that results in deregulation of AKT activation.
DISCUSSION
MEN2A mutations of RET tyrosine kinase receptor result in constitutive activation of RET via ligand-independent dimerization. Whether such mutations spread identical signaling to ligand-induced signaling was previously unclear. The present study revealed more complex alterations of MEN2A oncogenic signaling than previously thought and uncovered a critical node linked to a lipid raft environment that specifically controls the temporal activation of AKT.
Ligand-independent Dimerization of RET Exposes an Altered Regulation of AKT Activation-Studying MEN2A signaling to unravel alterations of RET signaling pathways is made difficult by the permanent activation of RET mutants. Indeed, MEN2A protein activation cannot be triggered in resting cells, precluding a rigorous comparison with the GFL-inducible signaling pathways. Thus, we reasoned that mimicking MEN2A activation with an inducible homodimerization system would help us understand the potential deregulation of RET signaling pathways involved in oncogenesis. Several pieces of evidence were obtained through these studies indicating that the addition of a binding module to the C terminus of RET did not obviously alter RET activation and function. This RET activation model readily showed that proximal RET signaling, i.e. RET autophosphorylation and phosphorylation of RET substrates such as PLC␥ and Shc, is very similar whether the receptor is activated with the natural ligand GDNF or the synthetic dimerizer AP. Therefore, the GDNF/GFR␣1 complex was not mandatory for efficient RET activation. This is in line with the studies of Liu et al. (36) , who demonstrated a comparable autophosphorylation pattern of wild type active RET and a MEN2A RET mutant. However, our model revealed that ligand-independent activation of RET translates into an altered tuning of the PI3K/AKT pathway, whereas the Ras/ERK pathway remained largely untouched. Thus, these data established that ligandindependent dimerization of RET leads to an altered regulation of specific signaling pathways.
A Role for Lipid Rafts in the Specific Control of the Tuning of AKT Activation-Given the wealth of data on the cellular processes regulated by AKT (28) , understanding the molecular mechanisms that underlie the deregulation of AKT activation is obviously of great interest. The RET isoform used throughout these studies is Ret9, in which the autophosphorylation site tyrosine 1062 is pivotal in the activation of both Ras/ERK and PI3K/AKT pathways (37) . In the current view, phosphorylated tyrosine 1062 drives both AKT and ERK activation through the same initial protein complexes, implicating sequentially Shc or FRS2 and Grb2. It is reasonable to assume that the differential regulation of AKT activation occurs downstream of Grb2 recruitment since proximal RET signaling and ERK activation are comparable whether RET is activated in a ligand-dependent or ligand-independent manner. New insight comes from the finding that a lipid raft environment is involved in this differential regulation of AKT. Although lipid rafts remain elusive membrane domains (8, 9) , our findings indicated that a lipid-based cholesterol-sensitive environment plays a key role in the temporal regulation of AKT activation. On the one hand, tight regulation of AKT activation by GDNF showed sensitivity to decrease in membrane cholesterol levels. Although cholesterol depletion can potentially influence general properties of the membrane (33) , it barely affected AP-mediated AKT activation, supporting a GDNF-specific sensitivity. On the other hand, cell fractionation experiments showed a clear difference in the (strength of) association of RET with DRMs following GDNF or AP stimulation. Although GDNF triggered an association, AP did not. Although the DRM association is a crude criterion to determine raft association (38, 39) , it can be interpreted as a reflection of a lipid raftrelated biochemical property of RET. Remarkably, this property is subjected to modulation and correlates with specific AKT regulation, providing strong support for a relationship with a biological process.
Our results are in agreement with a previous report showing that disruption of RET-GFR␣1 localization to DRMs did not alter GDNFinduced RET phosphorylation (4) . Disruption of localization to DRMs was achieved with the use of a transmembrane version of GFR␣1 (instead of a glycosylphosphatidylinositol linkage) that does not associate with DRMs. However, these authors found less robust AKT and ERK phosphorylation with no kinetic alteration. This contrasts with the altered kinetics of AKT phosphorylation and minimal effect on ERK phosphorylation we observed with the ligand-independent activation of RET. However, signaling events beyond 60 min after stimulation were not examined and thus cannot be compared with the late AKT activation we monitored (maximal at 120 min). The discrepancy for ERK activation remains unclear. It could reflect dissimilar constraints of the different cellular background used in the two studies, i.e. immortalized fibroblast as compared with a neuroblastoma cell line.
How could the association of RET with lipid rafts influence AKT regulation? The local environment at rafts may provide enrichment of distinct signaling targets that promote AKT regulation. For instance, the phosphoinositide lipid phosphatidylinositol-4,5-bisphosphate has been reported to accumulate in lipid rafts (40, 41) . Phosphorylation of phosphatidylinositol-4,5-bisphosphate by PI3K generates the important second messenger phosphatidylinositol-3,4,5-trisphosphate that is essential to the progress of the PI3K/AKT signaling cascade. Thus, an association with lipid rafts could conceivably increase the means for RET to trigger the PI3K/AKT cascade, resulting in rapid AKT activation. Conversely, potential raft-associated tyrosine or lipid phosphatases could accelerate the termination of AKT phosphorylation. We have examined the potential involvement of phosphatase and tensin homolog lipid phosphatase in the specific regulation of AKT phosphorylation but found no evidence for its recruitment in DRMs (not shown). Lipid rafts have also been implicated as an alternate mechanism to clathrindependent endocytosis (34) . Therefore, it is possible that RET activated by GDNF does not follow the same intracellular trafficking route, as MEN2A mutations activated RET. Different intracellular trafficking of receptors can have significant roles in controlling the nature of the activation pathway (45) . Thus, it is tempting to speculate that a raft-dependent versus a raft-independent internalization process of RET could contribute to the tuning regulation of AKT activation. Ongoing investigations should clarify these issues.
Controlled Dimerization of RET Provides a Useful Model to Study Some Aspects of Oncogenic MEN2A Signaling-Several pieces of evidence indicated that our model of AP-induced dimerization of RET is pertinent to study MEN2A signaling. First, in both cases, RET was activated by homodimerization of the protein in the absence of GFR␣1 and GDNF. Second, similar to what we observed in Rat-1 cells transformed by MEN2A RET mutants, chronic activation of RET with AP resulted in loss of contact inhibition. In marked contrast, contact inhibition did not take place under chronic activation of RET with GDNF. Such a difference is not mirrored in the anchorage-independent growth capability of the cells (27) , as both types of cellular stimulation led to a comparable number of formed macroscopic colonies in this assay (not shown). However, this operational test of malignancy may not be suitable to provide insights into the questions we addressed, as expression in cultured fibroblasts of other receptor tyrosine kinases, such as the epidermal growth factor receptor (42 ,43) , can lead to anchorage-independent growth when activated by ligands. Third, the controlled dimerization of RET predicts that MEN2A-induced elevated AKT activity (24) encompasses an altered tuning of its activation. Indeed, this activity appeared deregulated as when MEN2A mutants were forced to associate with DRMs through an interaction with GDNF/GFR␣1, AKT phosphorylation was strongly decreased. Such a decrease is of significance because the cells become more sensitive to anisomycin-induced apoptosis. It has been recently reported that a limited proportion of MEN2A RET mutants (7-8%) may constitutively associate with DRMs (44). We may not have detected such an association because of different experimental conditions, yet the cells are still left with a significant proportion of deregulated AKT. Whether the deregulated AKT activation contributes to loss of contact inhibition has been tentatively addressed by treating the cells with the commonly used PI3K inhibitors LY294002 or wortmannin. However, these drugs on their own lead to important Rat-1 cell death after a few days of culture. Thus, this requires further investigation.
A Reappraisal of MEN2A Signaling-Up to now, the model to explain how MEN2A RET mutants promote tumorigenesis has been left with the permanent nature of MEN2A signaling. Our results have brought new insight in this model. A key question in the field has been whether the intracellular activated RET precursor could contribute to the oncogenic potential of MEN 2A proteins. We have provided evidence that the RET precursor is able to phosphorylate the adaptor Shc but unable to trigger further activation of AKT or ERK. Although an indirect effect of the maturating blocking drugs used cannot be excluded, these results are consistent with a previous report suggesting that an activated RET precursor may not contribute to MEN2A-induced tumorigenesis (46) . Thus, our data provided support for MEN2A signaling originating pre-dominantly from the plasma membrane. In addition, our data revealed a complex situation in which MEN2A signaling is not identical to ligandinduced signaling but propagates qualitative differences in the PI3K/ AKT signaling pathway.
In conclusion, the present studies revealed that a lipid raft environment specifically controls the tuning of RET-mediated AKT activation, a control step that appears bypassed by MEN2A mutants. The challenges ahead are to pinpoint the molecular mechanisms that underlie the deregulation of AKT activation and to understand their connection with a lipid-based cholesterol-sensitive environment.
